Cutaneous melanoma incidence has increased in the last few decades over the world, including in Brazil.^[@r01]^ It is also considered the commonest malignant tumour found during pregnancy, corresponding to 31% of all diagnosed malignant neoplasms.^[@r02]^ Recent studies have reported an approximately 3.3% incidence of melanoma during pregnancy in women between 16 and 49 years old.^[@r02]^

In the last 50 years, non-controlled studies have suggested that hormonal factors may influence melanoma development, and consequently pregnancy may represent a higher risk of tumour development as well as a factor for unfavourable prognosis.^[@r03]^ Current evidence has not confirmed this. Controlled studies have shown that, until now, oral contraceptives and hormone replacement therapy do not increase the risk of developing melanomas, nor do endogenous hormones. For this reason, pregnancy does not seem to influence the development or prognosis of the disease (when corrected by tumour thickness and location factors).^[@r04]^

Another important aspect is the relationship between pregnancy and Breslow index. Breslow thickness is the main prognosis factor in patients diagnosed with melanoma. Some studies have suggested that women with melanoma diagnosed during pregnancy tend to present thicker tumours. Although there is the hypothesis of the involvement of hormonal changes and growth factors present in pregnancy, the most probable explanation would be a delay in its diagnosis.^[@r05]^

We describe a case of a 22 year old phototype II female, born and raised in São Paulo who reported a small dark brown mark in the third interdigital space of her right foot since birth. During her first pregnancy, she noted the mark increased in size and changed colour. At that time she was not examined for this dermatological complaint. Two years later, she sought dermatological evaluation, at which time an incisional biopsy was performed where the anatomical pathological findings were melanoma. At dermatological examination in our service, she presented a blackened plaque around the surgical ulceration (location of biopsy) in the third interdigital space of the right foot ([Figures 1](#f01){ref-type="fig"} and [2](#f02){ref-type="fig"}) and a painful palpable hardened mass on the root of right thigh measuring approximately 8 cm. Dermoscopy revealed a destructured lesion with areas of irregular multifocal pigmentation, coloured light brown, dark brown, black, and grey, as well as irregularly distributed brownish spots and globules and an amorphous grey-blue area. The centre presented a secondary scar area from a previous biopsy ([Figure 3](#f03){ref-type="fig"}). Review of the slide confirmed diagnosis of superficial spreading melanoma with a nodular component, Breslow index 6.3mm, Clark level IV, presence of ulceration with 5.5 mm extension, 13 mitoses in 10 high power fields, angiolymphatic invasion, absence of regression, and vertical growth phase ([Figures 4](#f04){ref-type="fig"} and [5](#f05){ref-type="fig"}). Metastatic tracking in solid organs was negative. Their laboratory exams were normal (including lactate dehydrogenase). Its stage was IIIC in line with the American Joint Cancer Commission Staging of Melanoma.^[@r06]^ The lesion was treated surgically followed by local graft and draining of the right inguinal lymphatic chain. After 6 months, the patient evolved with cerebral and pulmonary metastases, quickly evolving to death.

![Blackened plaque around the surgical ulcer in the third interdigital space of the right foot](abd-89-01-0157-g01){#f01}

![Another angle of the lesion in the third interdigital space of the right foot, which gives a better view of the blackened area](abd-89-01-0157-g02){#f02}

![Dermoscopy showing the destructured melanocytic lesion, irregular multifocal pigmentation with areas of light brown, dark brown, black, and grey, brown spots and globules with irregular distribution and an amorphous grey-blue area. The centre presents as an area of secondary scar tissue from a previous biopsy](abd-89-01-0157-g03){#f03}

![Histology: superficial disseminative melanoma with a nodular component, noting in the epidermis adjacent to the nodule (to the right) epidermotropism until the granulosa layer. (HE 40x)](abd-89-01-0157-g04){#f04}

![Histology: at higher magnification, note the intense nuclear atypia and mitotic figures. (HE 400x)](abd-89-01-0157-g05){#f05}

The relationship between pregnancy and melanocytic lesions has been discussed for many years. During pregnancy and exogenous hormone therapy, increased pigmentation is common in different areas of the body. Certain areas such as the mammary areole, armpits, genital region, and scar tissue are more prone to presenting increased pigmentation.^[@r07]^

Although recent studies have shown that pregnancy does not seem to promote melanoma, some works indicated that melanocytic nevi can undergo changes during pregnancy.^[@r04],[@r08]^ For example, Zampino et al. followed melanocytic lesions in pregnant women and showed that during pregnancy some melanocytic nevi underwent dermoscopic changes. However, these changes were transitory and the pigmented lesions returned to their original colour after childbirth.^[@r09]^

Zalaudek et al. also showed that multiple dysplastic nevi (MDN) present alterations in diameter and colouration during pregnancy.^[@r10]^ However, the main question is whether these alterations correspond to a normal finding or to a condition which raises suspicion of a diagnosis of melanoma. For this reason, pregnant women who present MDN should receive clinical and dermoscopic follow up.^[@r10]^

Probably in this case pregnancy may have precipitated the transformation of a congenital nevus into melanoma as the patient reported noticeable growth during pregnancy of a lesion present since birth.

The main objective of this report is to alert dermatologists to the need for careful examination of nevi and pigmented lesions during pregnancy. This case demonstrates that we must not interpret changes in these lesions as just being physiological. A biopsy should be immediately performed when a pigmented lesion changes dermoscopic character during pregnancy. This action could improve the early diagnosis and prognosis of primary cutaneous melanoma in these patients.
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